Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

As part of NeurologyLive®'s Year in Review, take a look at our top news articles in headache and migraine in 2024.

NeurologyLive® Year in Review 2024: Top Stories in Headache and Migraine

As part of NeurologyLive®'s Year in Review, take a look at our most-read news in stroke and cerebrovascular disease in 2024.

NeurologyLive® Year in Review 2024: Top Stories in Stroke and Cerebrovascular Disease

As part of NeurologyLive®'s Year in Review, take a look at our most-read news in epilepsy and seizure disorders in 2024.

NeurologyLive® Year in Review 2024: Top Stories in Epilepsy and Seizure Disorders

Mind Moments®, a podcast from NeurologyLive®, brings you a review of 2024, with insights from Daniel Ontaneda, MD, PhD; Ian Kremer; Andy Berkowski, MD, PhD; Sameea Husain-Wilson, DO; Jonathan Parker, MD, PhD; and Lawrence Robinson, MD. [LISTEN TIME:  minutes]

Neurology Unwrapped: 2024’s Most Intriguing Conversations

, has been with the team since September 2022. Follow her on Twitter 

With new revisions of the MS diagnostic criteria being made, clinicians highlighted key updates and the broader implications it has for diagnosis, treatment, and healthcare practices worldwide.

Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision 

IJMSC Insights offers a closer look at the latest research and the people behind it from the community of the International Journal of Multiple Sclerosis Care (IJMSC) and the Consortium of Multiple Sclerosis Centers (CMSC).

IJMSC Insights: Ahmed Zayed Obeidat on the Intersection of Art and Medicine

Assistant professor of pediatrics at the University of Michigan.

Videos

A duo of experts discussed the importance of addressing barriers such as provider comfort, access to genetic counselors, and insurance coverage to reduce diagnostic latency and standardize genetic testing for epilepsy. [WATCH TIME: 5 minutes]

Improving Access and Reducing Latency in Genetic Testing for Epilepsy: Julie Ziobro, MD, PhD; John Schreiber, MD

Assistant professor of neurosurgery and neuroscience at Mayo Clinic Arizona

The assistant professor of neurosurgery and neuroscience at Mayo Clinic Arizona discussed an ongoing early-stage study assessing the therapeutic potential of NRTX-1001 nerve cell therapy in drug-resistant unilateral mesial temporal lobe epilepsy. [WATCH TIME: 5 minutes]

Studying Nerve Cell Therapy NRTX-1001 to Treat Mesial Temporal Lobe Epilepsy: Jonathan Parker, MD, PhD

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AANEM 2024

AES 2024

CTAD 2024

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

Peers & Perspective page is a resource for sit-down video interviews between expert colleagues and peers on major topics in clinical practice and research.

1rem

Gabriel Pardo, MD, and Martin Belkin, DO, 

discuss how multiple sclerosis (MS) management now centers on detecting and mitigating progression independent of relapse activity (PIRA) through advanced biomarkers, early intervention, and personalized high-efficacy therapies targeting neurological preservation.

Investigating PIRA and Cognitive Functions in Multiple Sclerosis

Experts provide their clinical experience on identifying and managing smouldering multiple sclerosis, discussing the current treatment landscape and emerging approaches.

Expert Perspectives on the Management of Smouldering Multiple Sclerosis

Neurology experts discuss how patients with multiple sclerosis (MS) acquire disability and the concept of progression independent of relapse activity (PIRA). They also share recommendations on how to evaluate and care for cognitive decline and disease progression in patients with MS.

Disability Progression and Maintenance of Cognitive Function in Multiple Sclerosis

Experts in neurology discuss the use of oral therapies in the treatment of relapsing-remitting multiple sclerosis (MS). They discuss treatment selection based on long-term and real-world data and how recent and emerging therapies will change the management of patients with relapsing-remitting MS.

Updates in Current and Emerging Oral Treatment Options in Relapsing-Remitting Multiple Sclerosis

Advanced practice practitioners discuss the co-occurrence of sleep disorders with other health conditions, patient awareness, and the importance of screening for sleep disorders. They also discuss the treatment landscape of insomnia and the use of dual orexin receptor antagonists in the management of insomnia.

Advanced Practice Providers’ Perspectives on Sleep Disorders: Impact of Insomnia on Patient Health

Experts in neurology share considerations for the management of ethnically diverse and underrepresented populations including those of reproductive age.

Multiple Sclerosis Care in Diverse Patient Populations: Challenges and Solutions

Expert neurologists review updates in the management of Myasthenia Gravis.

Updates in the Management of Myasthenia Gravis Peers and Perspectives

Two multiple sclerosis experts discuss long-term and real-world data with oral therapies in the treatment of relapsing-remitting multiple sclerosis (RRMS) that was presented at ACTRIMS 2022.

Optimizing Treatment of Relapsing-Remitting Multiple Sclerosis with Oral Therapies

Experts in sleep medicine provide key insights on a series of patient cases and evaluate the use of novel agents in the treatment landscape for narcolepsy.

Improving Diagnosis and Patient Outcomes in Narcolepsy

Expert neurologists examine strategies for optimizing treatment formulations in the management of OFF episodes in Parkinson disease and highlight the importance of patient education.

Practical Considerations in the Management of OFF-Episodes in Parkinson Disease

Recommendations to neurologists on appropriately prescribing and managing patients with relapsing-remitting multiple sclerosis using novel, oral therapies.

Oral Therapy Options for Relapsing-Remitting Multiple Sclerosis

Elizabeth Thiele, MD, PhD, and Elaine C. Wirrell, MD, discuss the rare pediatric epilepsy conditions Dravet syndrome and Lennox-Gastaut syndrome, from prevalence to the approval of new therapies.

Rare Childhood Epilepsies: Dravet Syndrome and Lennox-Gastaut Syndrome							

Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the diagnosis, management, and treatment of Dravet Syndrome.

Comprehensive Management of Dravet Syndrome

Experts in the diagnosis and treatment of Alzheimer disease discuss the recent approval of aducanumab, its implications on the field, and other promising therapies and diagnostic technologies in development. 

Recent Breakthroughs in the Treatment of Alzheimer Disease

Elizabeth Thiele, MD, PhD, and Peter Crino, MD, PhD, discuss the diagnosis and management of tuberous sclerosis complex (TSC) as well as unmet needs in the field.

Management of Tuberous Sclerosis Complex

Vamshi K. Rao, MD, and Eric P. Hoffman, PhD, discuss how dystrophin relates to Duchenne Muscular Dystrophy, current approved therapies, and treatments in development.

Dystrophin and Its Role in Effective Treatment of Duchenne Muscular Dystrophy

A discussion regarding the stigma associated with migraine and the importance of empowering patients and health care professionals to become involved in migraine advocacy. 

The Patient-Centered Visit & Shared Decision Making in the Management of Migraine

Experts in neurology Laxman Bahroo, DO and Mindy K. Bixby, DO share insights into the diagnosis, management, and treatment of OFF episodes in Parkinson’s disease and highlight key therapeutic options currently available and in development.

Managing OFF Episodes in Parkinson’s Disease

Phyllis Zee, MD, PhD, and Alon Avidan, MD, MPH, provide an overview of behavioral and pharmacological approaches to the management of excessive daytime sleepiness (EDS) and narcolepsy and discuss the recent approval of agents with new mechanisms of action. 

Treating Narcolepsy and Excessive Daytime Sleepiness

Experts review the challenges of managing OFF episodes in Parkinson's disease and the current treatment options to optimize therapy. 